Press release
Masimo Announces Select Preliminary Full-Year 2020 Financial Results and 2021 Guidance
Complete fourth quarter and full-year 2020 financial results will be announced on Tuesday, February 23, 2021. Preliminary full-year 2020 product revenue of
About this update from Masimo Corporation
[{"type":"text","content":"\nComplete fourth quarter and full-year 2020 financial results will be announced on Tuesday, February 23, 2021.\n\n\nPreliminary full-year 2020 product revenue of approximately $1.139 billion to $1.144 billion;\n\n\nPreliminary full-year 2020 GAAP earnings per diluted share and non-GAAP earnings per diluted share are expected to exceed guidance of $3.77 and $3.46 per diluted share, respectively; and\n\n\nFull year 2021 financial guidance includes product revenue, GAAP earnings per diluted share and non-GAAP earnings per diluted share of approximately $1.200 billion, $3.81 and $3.80, respectively.\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (Nasdaq: MASI) today announced select preliminary financial and operational results for the full-year ended January 2, 2021 and provided estimates for its full-year 2021 financial guidance.\n\nPreliminary Full-Year 2020 Results:\n\nMasimo expects that its product revenue for the full-year 2020 will range from $1.139 billion to $1.144 billion, which reflects reported growth of 21.6% to 22.2% and constant currency growth of 21.6% to 22.1%, respectively. The Company also expects full-year 2020 shipments of noninvasive technology boards and instruments of approximately 472,000.\n\nAdditionally, Masimo expects that full-year 2020 GAAP earnings per diluted share and non-GAAP earnings per diluted share will exceed previously issued financial guidance of $3.77 and $3.46 per diluted share, respectively.\n\nThe preliminary financial information presented in this press release is based on Masimo’s current expectations and may be adjusted as a result of, among other things, completion of customary annual audit procedures. Management plans to discuss Masimo’s complete fourth quarter and full-year 2020 financial results after the market closes on Tuesday, February 23, 2021.\n\nLiDCO Transaction:\n\nThe Company recently announced that it had reached an agreement on the terms of a recommended cash offer to acquire the share capital of LiDCO Group Plc, a leading provider of advanced hemodynamic monitoring solutions (LiDCO). Masimo expects that the transaction will close in the first quarter and contribute approximately one percentage point to its full-year 2021 revenue guidance growth rate. Furthermore, the Company expects the transaction to be slightly dilutive to non-GAAP earnings per diluted...